Wellington Management Group LLP Form 8.3 - Sanofi (4936I)
02 Diciembre 2022 - 9:36AM
UK Regulatory
TIDM0A2V
RNS Number : 4936I
Wellington Management Group LLP
02 December 2022
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT,
1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing Wellington Management Group LLP
Company dealt in Sanofi
----------------------------------------------------------
Class of relevant security to which Ordinaru(FR0000120578)
the
dealings being disclosed relate
----------------------------------------------------------
Date of dealing 01 December 2022
----------------------------------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security
dealt in
Long Short
Number (%) Number (%)
----------------- --------- -------------------- --------
(1) Relevant securities 238,963 shares 0.02 % -21,195 shares 0.00 %
----------------- --------- -------------------- --------
Derivatives (other than
(2) options): -1,052 shares 0.00 %
-------------------------- ---------------------------- ----------------- --------- -------------------- --------
Options and agreements
(3) to purchase/sell: -11,935 shares 0.00 %
-------------------------- ---------------------------- ----------------- --------- -------------------- --------
Total 238,963 shares 0.02 % -34,182 shares 0.00 %
-------------------------- ---------------------------- ----------------- --------- -------------------- --------
(b) Interests and short positions in relevant securities of the company,
other than the
class dealt in
Class of relevant security: Long Short
Number (%) Number (%)
----------------- --------- -------------------- --------
(1) Relevant securities
-------------------------- ---------------------------- ----------------- --------- -------------------- --------
(2) Derivatives (other than
options):
-------------------------- ---------------------------- ----------------- --------- -------------------- --------
(3) Options and agreements
to purchase/sell:
-------------------------- ---------------------------- ----------------- --------- -------------------- --------
Total
-------------------------- ---------------------------- ----------------- --------- -------------------- --------
3. DEALINGS
(a) Purchases and sales
Purchase/sale Number of relevant Price per unit
securities
(b) Derivatives transactions (other than options transactions)
Product name Nature of Number of relevant Price per unit
e.g. CFD transaction securities
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name Writing, Number of Exercise Type, Expiry Option money
e.g. call purchasing, securities price e.g. American, date paid/ received
option selling, to which European per unit
varying etc. the option etc.
relates
(ii) Exercising
Product name Number of securities Exercise price per unit
e.g. call option
(d) Other dealings (including subscribing for new securities)
Nature of transaction Details Price per unit (if applicable)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the
person disclosing and any other person relating to the voting rights of
any relevant securities under any option referred to on this form or relating
to the voting rights or future acquisition or disposal of any relevant
securities to which any derivative referred to on this form is referenced.
If none, this should be stated.
None
Is a Supplemental Form 8 attached? YES
Date of disclosure 02 December 2022
Contact name Shaheen Hussain
--------------------
Telephone number 44-20-7126-6099
--------------------
If a connected EFM, name of offeree/offeror
with which connected
--------------------
If a connected EFM, state nature of connection
--------------------
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER
PANEL
ACT, 1997, TAKEOVER RULES, 2007 (AS AMED)
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form
8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS
Product name, e.g. call Written Number of relevant Exercise Type e.g. Expiry
option or purchased securities to price American, date
which option European
or derivative etc.
relates
-------
Equity Put Option Purchased 139 shares 58.0000USD American 16 Dec
22
-------------- ------------------- ----------- ----------- -------
Equity Put Option Purchased 139 shares 55.0000USD American 17 Mar
23
-------------- ------------------- ----------- ----------- -------
Equity Put Option Purchased 3,810 shares 61.0000USD American 20 Jan
23
-------------- ------------------- ----------- ----------- -------
Equity Put Option Purchased 3,811 shares 61.0000USD American 17 Feb
23
-------------- ------------------- ----------- ----------- -------
Equity Put Option Purchased 4,036 shares 53.0000USD American 30 Dec
22
-------------- ------------------- ----------- ----------- -------
Equity Swap Written 32 shares 15 May
23
-------------- ------------------- ----------- ----------- -------
Equity Swap Written 49 shares 15 May
23
-------------- ------------------- ----------- ----------- -------
Equity Swap Written 141 shares 05 May
23
-------------- ------------------- ----------- ----------- -------
Equity Swap Written 161 shares 15 May
23
-------------- ------------------- ----------- ----------- -------
Equity Swap Written 669 shares 15 May
23
-------------- ------------------- ----------- ----------- -------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ISEFZMGZKZVGZZM
(END) Dow Jones Newswires
December 02, 2022 10:36 ET (15:36 GMT)
Sanofi (LSE:0A2V)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Sanofi (LSE:0A2V)
Gráfica de Acción Histórica
De May 2023 a May 2024
